Hyderabad (Telangana) [India], Aug 19 (ANI): Dr Reddy's Laboratories on Wednesday announced the launch of Avigan (Favipiravir) 200 mg tablets in India for treatment of patients with mild to moderate COVID-19 disease.
Mumbai (Maharashtra) [India], April 30 (ANI): Glenmark Pharmaceuticals said on Thursday it has received approval from the Drug Controller General of India (DCGI) to conduct clinical trials on Favipiravir anti-viral tablets on COVID-19 patients.